No link between the use of bisphosphonates and the risk of cancer of the esophagus or stomach has also been noted in a recent large study from the UK. This […]

Impact Report IMPACT REPORT 2022 – 2023 2022 – 2023 __________   My Story My Story Karen Noel After 25 years as a teacher, many of them working with special […]

We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

Queen Elizabeth Hospital, PEI Brookfield Chair in Fracture Prevention funds new Fracture Liaison Service Program in Prince Edward Island With the generous support of PEI Department of Health and Wellness, […]

No link between the use of bisphosphonates and the risk of cancer of the esophagus or stomach has also been noted in a recent large study from the UK. This […]

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

Osteoporosis Canada hosted 60 delegates from all 10 provinces at FLS Forum 2017 on February 25th and 26th in Toronto. Current evidence on models to close the post-fracture care gap was presented and delegates […]

WILLS AND ESTATES Help Canadians Affected by Osteoporosis by Leaving a Gift in Your Will When you leave a gift to Osteoporosis Canada in your Will, you can feel confident […]

St. Clare’s Mercy Hospital in Newfoundland and Labrador St. Clare’s Mercy Hospital in Newfoundland and Labrador Breakfree Fracture Liaison Service (FLS) established in March 2024 New Breakfree Fracture Liaison Service […]